|
Re: circumstances under which lapatinib, not herceptin, might be the drug of choice
I think we're saying the same thing in a different way. Too bad there isn't a test to guide therapy choice. While/if they develop that, it would be good to know what makes the difference between Herceptin and Lapatinib effectiveness in p95 positive tumors.
|